Rossari Biotech Limited (ROSSARI) — Free Cash Flow Generation Index

Latest as of December 2023: 1.00x

Rossari Biotech Limited (ROSSARI) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of Rs301.76 Million represents 1% of operating cash flow (Rs301.76 Million). Explore Rossari Biotech Limited capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

Rs301.76 Million
INR

Operating Cash Flow

Rs301.76 Million
INR

Capital Expenditures

Rs0.00
INR

Rossari Biotech Limited Free Cash Flow Generation Index (2017–2025)

Historical FCF Generation Index trend for Rossari Biotech Limited across 9 annual periods. For the full cash flow conversion analysis, see ROSSARI operating cash flow.

Annual Free Cash Flow Generation for Rossari Biotech Limited (2017–2025)

Year-by-year Free Cash Flow Generation Index for Rossari Biotech Limited. Check how aggressively does Rossari Biotech Limited reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (INR) Operating CF Capital Expenditures YoY Change
2025 -0.15x Rs-210.69 Million Rs1.37 Billion Rs1.59 Billion ▲ +92.5%
2024 -2.04x Rs-880.28 Million Rs432.55 Million Rs1.31 Billion ▼ -359.5%
2023 0.78x Rs1.20 Billion Rs1.52 Billion Rs328.76 Million ▲ +359.7%
2022 -0.30x Rs-88.67 Million Rs293.58 Million Rs382.25 Million ▼ -39.8%
2021 -0.22x Rs-103.17 Million Rs477.67 Million Rs580.84 Million ▲ +44.0%
2020 -0.39x Rs-211.43 Million Rs548.28 Million Rs759.71 Million ▼ -201.0%
2019 0.38x Rs271.86 Million Rs711.77 Million Rs439.91 Million ▼ -16.1%
2018 0.46x Rs116.44 Million Rs255.69 Million Rs139.25 Million ▲ +173.1%
2017 0.17x Rs7.83 Million Rs46.95 Million Rs39.12 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).